Humacyte Inc HUMA
$0.64 $0.04 (5.75%) 1D
Last Updated: Aug 21, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
HUMA Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Humacyte Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Humacyte Inc. Stock Analysis HUMA
United States Health Care Micro Cap Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company is headquartered in Durham, North Carolina and currently employs 184 full-time employees. The company went IPO on 2020-09-22. The firm is engaged in developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues, advanced tissue constructs, and organ systems designed to improve the lives of patients and transform the practice of medicine. The firm develops and manufactures acellular tissues to treat a range of diseases, injuries, and chronic conditions. The company is using its proprietary, scientific technology platform to engineer and manufacture acellular tissue engineered vessels (ATEVs). The firm is also in late-stage clinical trials targeting other vascular applications, including arteriovenous (AV) access for hemodialysis and peripheral artery disease (PAD). The firm is also engaged in the preclinical development of coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple cell and tissue applications.
Humacyte Inc (HUMA) Chart
Financial Metrics & Statements of Humacyte Inc (HUMA)
FAQ's for Humacyte Inc (HUMA)
- As of August 2026, Humacyte Inc HUMA is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Humacyte Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Humacyte Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Humacyte Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Humacyte Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Humacyte Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Humacyte Inc (HUMA)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
